ArticleJournal of voice : official journal of the Voice Foundation2025
Delineating Effects of Stress-Analogous, Low-Dose Cortisol Exposure on Human Vocal Fold Fibroblasts.
Article in Journal of voice : official journal of the Voice Foundation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivePsychosocial stress results in an increase of circulating glucocorticoids in blood plasma that flows throughout the body. It is unclear whether stress-induced glucocorticoid exposure alters biological mechanisms of human vocal fold fibroblasts (hVFF). This study delineated the effects of stress-analogous cortisol exposure (100 nM) on healthy hVFF and lipopolysaccharide (LPS)-treated hVFF, in vitro.
methodsWe exposed hVFF to four conditions - cortisol-treated (100 nM, 7 days), LPS-treated, combined cortisol + LPS-treated, and an untreated control. Relative gene expression of inflammatory (IL1-β, TNF-α, transforming growth factor [TGF]-β1), glucocorticoid signaling (11β HSD1, glucocorticoid-induced leucine zipper [GILZ]), and fibrotic gene expression (ACTA2) was obtained. Alpha smooth muscle actin protein expression (α-SMA) was also measured via immunocytochemistry.
resultsStress-analogous cortisol exposure (cortisol-treated cells) significantly upregulated gene expression of GILZ and pro-fibrotic marker (ACTA2) and downregulated expression of IL1-β when compared to untreated controls (P < 0.05). LPS-treated cells significantly upregulated expression of inflammatory cytokines compared to untreated control cells (IL1-β, P = 0.003; TNF-α, P < 0.001; TGF-β1, p = 0.031). Cortisol + LPS-treated cells upregulated expression of IL1-β, when compared to LPS-treated cells (P = 0.028). Immunocytochemistry revealed positive expression of α-SMA in the cortisol + LPS-treated cells only.
conclusionStress-analogous cortisol exposure inhibits inflammatory cytokines, upregulates glucocorticoid signaling, and pro-fibrotic gene targets in hVFF. The combination of stress-analogous cortisol exposure and LPS upregulated inflammatory cytokines, glucocorticoid signaling gene expression, and protein expression of α-SMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.